Treating mice bearing CRC cells with PF-03084014 (125 mg/kg), alone or combined with irinotecan, for 28 days resulted in a significant reduction in tumor recurrence and tumor growth and also decreased the ALDH+ population. The gene discussed is LDHA; the disease is neoplasm.